No Data
No Data
Beyond The Numbers: 7 Analysts Discuss Lexicon Pharmaceuticals Stock
Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and Travere Therapeutics (TVTX)
Shareholders in Lexicon Pharmaceuticals (NASDAQ:LXRX) Have Lost 68%, as Stock Drops 8.9% This Past Week
Lexicon to Present Phase 3 Trial Design for Sotagliflozin in Hypertrophic Cardiomyopathy (HCM) at Upcoming Medical Congress
Lexicon Pharma: Search for a New Chief Fincl Officer Is Ongoing >LXRX
Lexicon Pharma : Jeff Wade, Pres and Oper Chief, to Step Down to Pursue New Outside Opportunities >LXRX
No Data
No Data